References
Malizos KN, Karantanas AH, Varitimidis SE, Dailiana ZH, Bargiotas K, Maris T (2007) Osteonecrosis of the femoral head: etiology, imaging and treatment. Eur J Radiol 63(1):16–28
Shim K, MacKenzie MJ, Winquist E (2008) Chemotherapy-associated osteonecrosis in cancer patients with solid tumours: a systematic review. Drug Saf 31(5):359–371
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30(2):239–245
Guillet M, Walter T, Scoazec JY, Vial T, Lombard-Bohas C, Dumortier J (2009) Sorafenib-Induced Bilateral Osteonecrosis of Femoral Heads. J Clin Oncol
Kabata T, Matsumoto T, Yagishita S, Wakayama T, Iseki S, Tomita K (2008) Vascular endothelial growth factor in rabbits during development of corticosteroid-induced osteonecrosis: a controlled experiment. J Rheumatol 35(12):2383–2390
Varoga D, Drescher W, Pufe M, Groth G, Pufe T (2009) Differential expression of vascular endothelial growth factor in glucocorticoid-related osteonecrosis of the femoral head. Clin Orthop Relat Res 467(12):3273–3282
Conflict of interest
The authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mir, O., Coriat, R., Gregory, T. et al. Avascular necrosis of the femoral head: a rare class-effect of anti-VEGF agents. Invest New Drugs 29, 716–718 (2011). https://doi.org/10.1007/s10637-010-9406-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10637-010-9406-6